The Indian strain is fast becoming dominant in the UK which has the government implementing plans for a third booster dose later this year. Meanwhile India is seeing a new emerging nightmare consequence of covid-19 - black mold disease, an opportunist fungal disease which is related to high blood sugar levels i.e. diabetes which is at epidemic levels in India that now the black mold disease is capitalising upon due to immune system impaired covid-19 infections. Black Mold KILLs tissue and if untreated has a fatality rate of 94%! Far in excess of covid-19! Though it can be treated in the early stages with anti-fungal's but if left unchecked would require expensive specialist treatment i.e. surgical intervention to remove the dead tissue.

Hospitals in India are reporting a surge in patients infected with black mold disease across 29 states, for instance 1 large state hospital (Maharaji Yehswantrao) is reporting 185 cases during the weekend alone when the hospital was used to experiencing 2 cases per year and has become more challenging than Covid-19 in terms of hospital resources. This illustrates the broader danger of covid in that it can allow opportunist killers to gain a foothold on a population where the healthcare system has been brought to a state of collapse.

Meanwhile India continues to under report the true extent of the pandemic with actual deaths likely 5 times official numbers, so around 15 deaths per million people per day as does likely most of Africa to an even greater extent. The pandemic also continues to worsen in most of the South American nations.

So covid looks like becoming a permanent income stream for pharma's, both in terms of vaccines and treatments such as anti fungal's for the emerging consequences such as Black Mold disease.

The rest of this extensive analysis that concludes in my latest biotech stocks with the potential to X10 over the coming years Five More Small Cap Bio and Tech Stocks to Invest for 2021 and Beyond! has first been made available to Patrons who support my work.

Topics Include:

Invest and Forget
Stock Market Early Summer Correction Review
AI Stocks Strength vs Weakness
RAMPANT MONEY PRINTING INFLATION BIG PICTURE!
HIGH RISK STOCK BUYING LEVELS
RISK RATINGS
WESTERN DIGITAL - WDC $71 - CHIA! - Risk 1
Life Sciences Biotech Smaller Cap High Risk Stocks Investing Binge
Biotech stock 1 - Cheap Low Risk Pharma - Risk 1
Biotech stock 2 - HIGH RISK GENE EDITING - Risk 9
Biotech stock 3 - Low Risk 2
Biotech stock 4 - X10 for Max Risk 10
High Risk Stocks Portfolio Buying Levels
Covid India Black Mold Epidemic
Bitcoin and Raven Coin Buying Levels

So for immediate first access to ALL of my analysis and trend forecasts then do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

My analysis schedule includes:

Bitcoin Trend Forecast - 50% done
More X10 Biotech Tech Stocks - 40% done
UK House Prices Trend Analysis - 10% done
How to Get Rich! - 70% done
US Dollar and British Pound analysis
Gold and SIlver Price Analysis

Again for immediate access to all my work do consider becoming a Patron by supporting my work for just $3 per month. https://www.patreon.com/Nadeem_Walayat.

And ensure you are subscribed to my ALWAYS FREE newsletter for my next in-depth analysis.

Your analyst investing in biotech stocks.

Nadeem Walayat

http://www.marketoracle.co.uk

Nadeem Walayat has over 30 years experience of trading derivatives, portfolio management and analysing the financial markets, including one of few who both anticipated and Beat the 1987 Crash. Nadeem's forward looking analysis focuses on UK inflation, economy, interest rates and housing market. He is the author of five ebook's in the The Inflation Mega-Trend and Stocks Stealth Bull Market series that can be downloaded for Free.

Nadeem is the Editor of The Market Oracle, a FREE Daily Financial Markets Analysis & Forecasting online publication that presents in-depth analysis from over 1000 experienced analysts on a range of views of the probable direction of the financial markets, thus enabling our readers to arrive at an informed opinion on future market direction. http://www.marketoracle.co.uk

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any trading losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors before engaging in any trading activities.

Nadeem Walayat Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.